SEER Prakiraan rega marang bathi Seer Inc

Logo korporat perusahaan Seer Bio (SEER)

Seer, Inc. (SEER) specializes in developing high-tech systems for protein study, leveraging stable operations in Europe and the US without significant geopolitical threats. This daily price chart with the 0.00 indicator clearly demonstrates the company's dynamics. However, financial stability is subject to the impact of substantial innovation costs, a lack of profitability, and the slow adoption of new analytical methods in medicine.

SEER - Kapitalisasi marang proyeksi bathi seer.bio ing rentang 04.07.2022 - 13.11.2026

Rincian metrik keuangan lan pasar Seer Bio (SEER)

- nilai saham lan prakiraan konsensus rega:
Bagan rega Seer|SEER - Target median analis
- data kapitalisasi pasar:
Biji pasar Seer Inc|SEER - Total Nilai Bisnis
- statistik nilai buku emiten:
Nilai Buku saben Saham Seer|SEER - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku seer.bio|SEER - Gunggung Aset Perusahaan
- informasi babagan utang lan solvabilitas:
Rasio Total Utang marang Ekuitas Seer, Inc.|SEER - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Seer, Inc.|SEER - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Seer Inc|SEER - Utang jangka dawa|Utang jangka cendhak perusahaan Seer|Rasio cepet seer.bio
- statistik bathi lan rasio pasar:
SEER - Asil keuangan resik|Proyeksi bathi mangsa ngarep Seer, Inc.|SEER - Koefisien rega marang bathi|Pangali Forward P/E Seer Inc.|SEER - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Seer Inc|SEER - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Seer|SEER - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan seer.bio|SEER - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Seer, Inc.
Analisis fundamental perusahaan:Seer
Sampel barang Seer, Inc.

The forward P/E compares the current quote to expected net income, accounting for potential cash flow gaps. This metric assesses the business value relative to its projected efficiency and ability to service obligations. For Seer, Inc. (SEER), this is critical due to high capital burn and the complexity of implementing proteomic technologies. Competition risks from industry leaders directly impact the calculated yield. By analyzing the company's forward P/E value, an investor can track the dynamics of market expectations regarding capitalization.

Pesaing Seer, Inc. (SEER)

Rega marang bathi mangsa ngarep Abbott (ABT)|Kapitalisasi marang proyeksi bathi Thermo Fisher Scientific Inc.|GE Healthcare Corp - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep MTD (Mettler Toledo Inc)|Waters Corporation - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi bio-techne.com TECH|BRKR: Pangali Forward P/E|Prakiraan rega marang bathi Azenta Inc|Prakiraan rega marang bathi VREX|SMLR: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Butterfly Network, Inc. (BFLY)|Prakiraan rega marang bathi mesalabs.com MLAB|Pangali Forward P/E QSI (Quantum-Si Incorporated)|Nano-X Imaging (NNOX) - Rasio prakiraan rega marang bathi|Quanterix Corp - Pangali Forward P/E|MASS (908 Devices Corporation) - Rasio rega marang bathi mangsa ngarep|CV: Pangali Forward P/E|MXCT - Kapitalisasi marang proyeksi bathi|RPID (Rapid Micro Biosystems Inc.) - Pangali Forward P/E|Prakiraan rega marang bathi Hyperfine Inc (HYPR)|Pangali Forward P/E FONR|Pangali Forward P/E daxor.com (DXR)|Rega marang bathi mangsa ngarep Spectral AI MDAI|organovo.com - Rega marang bathi mangsa ngarep|ACON: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi AKYA (Akoya Biosciences)|THMO: Pangali Forward P/E|Rasio prakiraan rega marang bathi Talis Biomedical Corporation (TLIS)|Rega marang bathi mangsa ngarep T2 Biosystems, Inc.